U.S. market Closed. Opens in 44 minutes

CPHI | China Pharma Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312005-06-302004-06-302003-06-302002-06-30
Revenue7.01M8.10M9.64M10.87M10.92M12.33M13.21M15.57M20.35M24.93M32.81M54.51M81.17M74.39M61.70M50.97M33.19M21.84M8.66MN/A23.27K110.08K37.49K
Cost of Revenue7.52M8.60M9.29M8.91M9.44M10.36M10.74M12.35M18.89M19.47M33.29M40.43M52.18M44.11M36.05M25.68M17.62M11.75M4.17MN/A47.68KN/AN/A
Gross Profit-504.88K-493.92K349.27K1.95M1.48M1.97M2.47M3.22M1.46M5.46M-480.92K14.08M28.99M30.28M25.65M25.29M15.57M10.10M4.49MN/A-24.41KN/A37.49K
Operating Expenses2.25M3.15M3.46M4.42M4.87M-12.42M5.57M6.33M5.51M7.80M7.37M6.71M6.96M6.09M3.04M5.56M3.32M1.47M247.03K1.84M92.96K265.72K752.32K
Selling, General & Admin2.01M2.87M3.15M4.04M4.64M5.77M5.48M6.30M6.19M5.06M5.69M6.85M7.16M5.58M4.85MN/AN/AN/A247.03K1.84MN/AN/A752.32K
Research & Development240.08K185.86K318.96K377.96K229.64K172.38K90.47K365.97K961.90K2.80M1.68MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A93.85KN/A115.19B7.58TN/AN/A-343.02K-1.64M-65.11KN/A-141.99K-193.59K505.22K-1.82M5.56M3.32M1.47MN/AN/A92.96K265.72KN/A
Operating Income-2.75M-3.55M-3.12M-2.46M-3.39M-3.97M-18.68M-8.16M-4.05M-2.33M-7.85M7.37M22.03M24.20M22.61M19.73M12.25M8.62M4.24M-1.84M-117.37K-155.64K-714.83K
Other Expenses / Income-327.00K-423.86K-283.75K-409.35K-17.31M-6.89M-15.58M-718.98K-11.30M-23.64M-11.09M-1.77M686.27K1.91M-119.95K-189.04K405.43K-36.41K-192.16KN/A-381.33K-24.53K-389.30K
Before Tax Income-3.08M-3.97M-3.40M-2.87M-20.70M-10.86M-19.15M-8.87M-15.35M-25.97M-18.95M5.60M22.71M26.10M22.49M19.54M12.66M8.59M4.05MN/AN/AN/A-1.10M
Income Tax Expenses-4.006.25M542.00K294.16K321.72K109.99K122.63K308.18K60.44K77.04K1.06M983.92K3.44M2.69M2.26M1.71M-162.87KN/A252.10KN/AN/AN/AN/A
Net Income-3.08M-10.22M-3.94M-3.16M-21.02M-10.75M-19.28M-9.18M-15.41M-26.05M-20.01M4.62M19.27M23.41M20.23M17.83M12.82M8.59M3.80M-1.84M-504.29K-226.37K-1.10M
Interest Expenses333.60K-423.86K542.00K294.16K321.72K-412.74K539.33K849.56K1.17M785.80K348.70K308.38K255.20K168.26K154.18K131.03K237.40K145.88K186.45KN/A5.59KN/A49.85K
Basic Shares Outstanding3.38M5.26M4.61M4.36M4.36M4.36M43.58M43.58M43.58M43.58M43.58M43.58M43.48M43.33M42.28M40.22M37.01M34.72M11.29M837.14K565.45K326.94K283.18K
Diluted Shares Outstanding3.38M5.26M4.61M4.36M4.36M4.36M43.58M43.58M43.58M43.58M43.58M43.58M43.48M43.53M42.28M40.22M37.26M34.72M11.29M837.14K565.45K326.94K283.18K
EBITDA1.83K-848.44K-24.87K222.04K-433.26K-709.62K-15.32M-4.95M-10.58M-23.40M-16.99M7.37M24.14M27.77M24.02M20.39M13.32M9.13M4.49M-1.84M5.49K-159.09K-970.97K
EBITDA Margin0.03%-10.47%-0.26%2.04%-3.97%-5.75%-115.98%-31.77%-51.99%-93.87%-51.77%13.53%29.74%37.34%38.93%40.01%40.13%41.80%51.84%0.00%23.60%-144.53%-2,589.95%
EBIT-2.75M-4.40M-2.86M-2.57M-20.38M-11.05M-18.62M-8.02M-14.18M-25.18M-18.60M5.91M22.97M26.27M22.65M19.67M12.89M8.73M4.24M-1.84M-498.70K-226.37K-1.05M
EBIT Margin-39.15%-54.25%-29.64%-23.67%-186.57%-89.64%-140.90%-51.54%-69.67%-101.03%-56.69%10.84%28.30%35.31%36.71%38.60%38.85%39.98%48.95%0.00%-2,142.63%-205.64%-2,812.16%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312005-06-302004-06-302003-06-302002-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙